Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Radermecker

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Diabetes/Metabolism Research and Reviews|January 12, 2007
Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analoguesR P Radermecker, A J Scheen
Revue Medicale De Liege|August 17, 2006
[Effects of glimepiride (Amarylle) in type 2 diabetic patients: results of the Belgian study RECORD in general medicine]R P Radermecker, A J Scheen,
Diabetes & Metabolism|January 8, 2011
Management of blood glucose in patients with strokeR P Radermecker, A J Scheen
Revue Medicale De Liege|July 23, 2005
[Inhaled insulin, new perspective for insulin therapy]R P Radermecker, J L Sélam
Revue Medicale Suisse|September 16, 2006
[Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy]R P Radermecker, A J Scheen
Revue Medicale De Liege|October 31, 2007
[Drug of the month. Ezetimibe/simvastatin tablet (Inegy)]A J Scheen, R P Radermecker
Revue Medicale De Liege|December 31, 2008
[Biphasic insulin aspart (NovoMix 50)]R P Radermecker, A J Scheen
Revue Medicale De Liege|August 16, 2012
[Type 1 diabetes: from genetic predisposition to hypothetical environmental triggers]J-C Phlips, R P Radermecker
Revue Medicale De Liege|June 5, 2020
[Therapeutic and technological advances in the management of adult patients with type 1 diabetes]R P Radermecker, J C Philips
Diabetes/Metabolism Research and Reviews|June 5, 2009
Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose controlR P Radermecker, E Renard, A J Scheen
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Diabetes/Metabolism Research and Reviews|January 12, 2007
Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analoguesR P Radermecker, A J Scheen
Revue Medicale De Liege|August 17, 2006
[Effects of glimepiride (Amarylle) in type 2 diabetic patients: results of the Belgian study RECORD in general medicine]R P Radermecker, A J Scheen,
Diabetes & Metabolism|January 8, 2011
Management of blood glucose in patients with strokeR P Radermecker, A J Scheen
Revue Medicale De Liege|July 23, 2005
[Inhaled insulin, new perspective for insulin therapy]R P Radermecker, J L Sélam
Revue Medicale Suisse|September 16, 2006
[Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy]R P Radermecker, A J Scheen
Revue Medicale De Liege|October 31, 2007
[Drug of the month. Ezetimibe/simvastatin tablet (Inegy)]A J Scheen, R P Radermecker
Revue Medicale De Liege|December 31, 2008
[Biphasic insulin aspart (NovoMix 50)]R P Radermecker, A J Scheen
Revue Medicale De Liege|August 16, 2012
[Type 1 diabetes: from genetic predisposition to hypothetical environmental triggers]J-C Phlips, R P Radermecker
Revue Medicale De Liege|June 5, 2020
[Therapeutic and technological advances in the management of adult patients with type 1 diabetes]R P Radermecker, J C Philips
Diabetes/Metabolism Research and Reviews|June 5, 2009
Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose controlR P Radermecker, E Renard, A J Scheen
Pageof 6